Live from the NIH registry
Studies recruiting near Greenville right now
Top 25 of 378 recruiting studies, sorted by proximity — each links to its official registry page
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Greenville, South Carolina (2.0 mi)
· Sponsor: AstraZeneca
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Greenville, South Carolina (2.0 mi)
· Sponsor: Dren Bio
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
AnMed Health Pulmonary and Sleep Medicine — Anderson, South Carolina (28.1 mi)
· Sponsor: Synairgen Research Ltd.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
AnMed Health Medical Center — Anderson, South Carolina (28.1 mi)
· Sponsor: Duke University
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Saint Francis Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: NRG Oncology
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Spartanburg — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Altesa Biosciences, Inc.
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Carolina Ottobock.care — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Greenville, South Carolina (2.0 mi)
· Sponsor: AstraZeneca
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
Phase 3
Interventional 160 participants sought
Palmetto Clinical Trial Services, LLC — Greenville, South Carolina (2.0 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Saint Francis Health System ( Site 0089) — Greenville, South Carolina (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Saint Francis Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
Bon Secours St. Francis Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: Sellas Life Sciences Group
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (2.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Other
N/A
Interventional 97 participants sought
Prisma Health Cancer Institute - Faris — Greenville, South Carolina (2.0 mi)
· Sponsor: Wake Forest University Health Sciences
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Supratentorial Hemorrhage
N/A
Observational 500 participants sought
Prisma Health - Upstate — Greenville, South Carolina (2.0 mi)
· Sponsor: Integra LifeSciences Corporation
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Carolina Nephrology, PA — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Tribe Clinical Research at Parkside Pediatrics Five Forks — Simpsonville, South Carolina (9.2 mi)
· Sponsor: Pfizer